SLED Weekly Market Update on COVID-19
Published: August 05, 2022
A look into the State, Local, and Education Market's response to COVID-19
In the 30th week of 2022, State and Local procurement continued to react to the COVID-19 pandemic this week. As COVID-19 and its variants continue to spread, many government agencies are maintaining regulations surrounding procurements to protect the safety of their employees and the vendors interested in doing business with them. Mandatory in-person pre-bid conferences have been moved online, proposals have been asked to be delivered electronically, and in instances where site visits are required they’ve been scheduled one at a time instead of en masse.
Again, California is at the top of the list with New Jersey close in second place. New York, Texas, and Illinois followed closely behind for the most COVID related procurement this week. This list may continue to shuffle throughout the year as the vaccine roll out progresses.
Once again, most activity continues at the State Department level. The City remains second, County third, and Independent School Districts fourth. Special District, Colleges/Universities, and Tribal Governments had the least movement among these entities.
The most common smart tags were paving trades, electrical trades, HVAC trades, site work services, and road transportation infrastructure construction services.
Notable recent awards:
- Pennsylvania - THIS GRANT AGREEMENT PROVIDES FUNDING TO H.E.A.R, INC. DBA THE GATEHOUSE FOR PROVIDER STABILIZATION DUE TO THE COVID-19 PANDEMIC
- Pennsylvania - THIS AMENDMENT REQUIRES THAT GINKGO BIOWORKS INC PROVIDE COVID-19 TESTING SERVICES TO ANY K-12 SCHOOL IN THE COMMONWEALTH THAT OPTS INTO THE DEPARTMENT'S TESTING PROGRAM FOR THE 2021-2022 ACADEMIC SCHOOL YEAR
- Pennsylvania - COVID-19 VACCINE OUTRECH GRANT CONTRACT
Featured grant of the week:
RFA-DK-22-016 - Department of Health and Human Services - National Institutes of Health - Understanding the Pathophysiology and Clinical Course of New-Onset Diabetes Following COVID-19 (U01 Clinical Trial Not Allowed). Current Closing Date for Applications: December 20, 2022
Please watch for continued information from Deltek and the GovWin IQ team on agency needs associated with coronavirus efforts.